We are live on ! Find out more
AURA icon

Aura Biosciences
AURA

44 hedge funds and large institutions have $224M invested in Aura Biosciences in 2022 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 24 increasing their positions, 5 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

380% more repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 5

29% more funds holding

Funds holding: 34 → 44 (+10)

7.08% more ownership

Funds ownership: 46.9% → 53.98% (+7.1%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

25% less capital invested

Capital invested by funds: $299M → $224M (-$75M)

Holders
44
Holders Change
+10
Holders Change %
+29.41%
% of All Funds
0.74%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
11
Increased
24
Reduced
5
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$10.1M
2
RCM
Regency Capital Management
Hawaii
+$4.21M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$3.42M
4
State Street
State Street
Massachusetts
+$2.84M
5
Citigroup
Citigroup
New York
+$2.03M

Top Sellers

Rank Fund Capital Flow
1
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$338K
2
Barclays
Barclays
United Kingdom
-$290K
3
Citadel Advisors
Citadel Advisors
Florida
-$74.4K
4
Wells Fargo
Wells Fargo
California
-$13.1K
5
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$4K
Name Holding Trade Value Shares
Change 		Change in
Stake
MCMC
1
Matrix Capital Management Company
New Hampshire
$58.3M – – –
MVM
2
Medicxi Ventures Management
Jersey
$43.1M – – –
Citadel Advisors
3
Citadel Advisors
Florida
$32.8M -$74.4K -4,494 -0.2%
Adage Capital Partners
4
Adage Capital Partners
Massachusetts
$18.1M -$338K -20,400 -2%
RSCM
5
Rock Springs Capital Management
Maryland
$14.3M +$11.6K +700 +0.1%
BlackRock
6
BlackRock
New York
$12.6M +$10.1M +611,696 +222%
Fidelity Investments
7
Fidelity Investments
Massachusetts
$8.55M +$1.81M +109,362 +22%
Vanguard Group
8
Vanguard Group
Pennsylvania
$6.17M +$3.42M +206,542 +90%
NCM
9
Nantahala Capital Management
Connecticut
$4.86M +$682K +41,225 +14%
State Street
10
State Street
Massachusetts
$3.64M +$2.84M +171,764 +202%
RCM
11
Regency Capital Management
Hawaii
$3.61M +$4.21M +254,622 New
DCMIC
12
Decheng Capital Management III (Cayman)
Cayman Islands
$2.98M – – –
Geode Capital Management
13
Geode Capital Management
Massachusetts
$2.94M +$1.69M +101,960 +97%
Northern Trust
14
Northern Trust
Illinois
$1.88M +$1.43M +86,621 +188%
Citigroup
15
Citigroup
New York
$1.75M +$2.03M +122,969 +56,150%
UOC
16
UBS O'Connor
Illinois
$1.28M +$1.5M +90,539 New
Allianz Asset Management
17
Allianz Asset Management
Germany
$873K +$106K +6,430 +12%
N
18
Nuveen
North Carolina
$868K +$1.01M +61,227 New
Morgan Stanley
19
Morgan Stanley
New York
$772K +$884K +53,430 +4,818%
Charles Schwab
20
Charles Schwab
California
$610K +$457K +27,630 +180%
Barclays
21
Barclays
United Kingdom
$598K -$290K -17,511 -29%
Bank of New York Mellon
22
Bank of New York Mellon
New York
$569K +$424K +25,600 +177%
Bank of America
23
Bank of America
North Carolina
$501K +$389K +23,486 +198%
Millennium Management
24
Millennium Management
New York
$325K +$379K +22,917 New
RhumbLine Advisers
25
RhumbLine Advisers
Massachusetts
$294K +$343K +20,713 New
1
2

AURA Hedge Fund Activity: Q2 2022 in Review

44 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in Aura Biosciences (AURA) for Q2 2022, worth a combined $224M — down 25% from $299M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new AURA positions and 0 closed out — a net gain of 11 holders — while 24 added to existing stakes and 5 trimmed.

The largest buyer was BlackRock, adding an estimated $10.1M. The largest seller was Adage Capital Partners, cutting an estimated $338K.

  • 44 institutional investors held Aura Biosciences (AURA) as of Q2 2022, up from 34 in Q1 2022.
  • Funds reported $224M of Aura Biosciences stock for Q2 2022, down 25% quarter-over-quarter.
  • 11 funds opened new Aura Biosciences positions in Q2 2022 and 0 closed out, a net change of +11 holders.
  • The largest Aura Biosciences buyer in Q2 2022 was BlackRock, an estimated $10.1M added.
  • The largest Aura Biosciences seller in Q2 2022 was Adage Capital Partners, an estimated $338K sold.

Based on aggregated 13F filings for Q2 2022.